The institute's employees won a prize in the competition
06  10.2025
The poster competition was held as part of the Thirty-first United Russian Gastroenterology Congress.
The head of the Institute's Center for the Prevention and Control of AIDS held educational sessions with teachers
03  10.2025
The classes were held as part of a series of events within the large-scale educational project "Sanprosvet" Lecture Hall.

An institute employee presented a report at the Virology Days 2025 forum in St. Petersburg

Home  »  Health education  »  Health education news  »  An institute employee presented a report at the Virology Days 2025 forum in St. Petersburg
Print version
An institute employee presented a report at the Virology Days 2025 forum in St. Petersburg
29  09.2025
The VI International Forum "Days of Virology 2025" was held on September 22-23, 2025.

Over 800 specialists participated in the forum. The program addressed numerous current issues in modern virology, with a strong focus on the treatment and prevention of viral infections.

A separate section of the forum was devoted to the development of new approaches to creating innovative vaccines for the prevention of infectious diseases. Viktor Vladimirovich Novikov, Head of the Immunochemistry Laboratory at the I.N. Blokhina Novosibirsk Research Institute of Epidemiology and Microbiology (Rospotrebnadzor), Honored Scientist of the Russian Federation, Professor, and Doctor of Biological Sciences, delivered a presentation at the section. In his presentation, "Chimeric Norovirus Proteins as the Basis for Antiviral Vaccines," he described our institute's new immunobiotechnological developments aimed at creating innovative vaccines. The Immunochemistry Laboratory, in collaboration with specialists from other departments at the institute, has developed a molecular platform for constructing virus-like particles based on the norovirus capsid protein. Particles constructed from chimeric recombinant proteins can serve as the antigen base for vaccines. Using the developed platform, vaccine prototypes were created for the prevention of COVID-19, norovirus, and echovirus E30, which causes viral serous meningitis.